IL17A and atherosclerosis: Molecular biological research on the treatment of MN with Tripterygium glycosides, according to the principles of traditional Chinese medicine, the effects of treatment with Tripterygium glycosides mainly involves the AGE-RAGE signaling pathway, lipids and atherosclerosis, the IL-17 signaling pathway, fluid shear stress, atherosclerosis, and the NF-κB signaling pathway to regulate the release of inflammatory factors and T cell proliferation [13–15].